Charles C Chu

6PUBLICATIONS
12CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)MechanobiologyMicrobial taxonomyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 02, 2025
Treatment of Relapsed/Refractory CLL Patients With PI3Kδ Inhibitor and Anti-CD20 Antibody Rapidly Decreases Tumor Burden but Could Induce Resistance.

Jennifer E Bruno, Christine A Herne, Andrea M Baran

|Jul 24, 2023
Long-term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial Bruton tyrosine kinase inhibitors therapy for chronic lymphocytic leukemia or lymphoplasmacytic lymphoma.

Michael T Brady, Nathan Laniewski, Myla Strawderman

|Sep 29, 2021
Moderate dose alcohol protects against serum amyloid protein A1-induced endothelial dysfunction via both notch-dependent and notch-independent pathways.

Naresh K Rajendran, Weimin Liu, Charles C Chu

|Oct 31, 2020
Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma.

Clive S Zent, Michael T Brady, Carolyne Delage

|Feb 02, 2020
High-resolution quantification of discrete phagocytic events by live cell time-lapse high-content microscopy imaging.

Charles C Chu, Jonathan J Pinney, Hannah E Whitehead

|Aug 10, 2018
Cellular Cytotoxicity of Next-Generation CD20 Monoclonal Antibodies.

Karl R VanDerMeid, Michael R Elliott, Andrea M Baran

Pageof 1

Frequent Collaborators

3 joint publications

Paul M Barr

3 joint publications

Clive S Zent

2 joint publications

Nathan Laniewski

2 joint publications

Mark Y Sangster